Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials

Mobile sensors offer enormous potential for the collection of informative clinical endpoints in clinical trials to support regulatory decision making and product labelling. There are currently no specific guidelines on the information needed to enable regulators to review and accept proposed endpoints derived from mobile sensors for use in drug development trials.

Source: Contemporary Clinical Trials - February 18, 2020 Category: Radiology Authors: M.K. Walton, J.C. Cappelleri, B. Byrom, J.C. Goldsack, S. Eremenco, D. Harris, E. Potero, N. Patel, E. Flood, M. Daumer Tags: Review Source Type: research